However, the number of studies and clinical trial examples demonstrating the effects of the FOXP3 signaling pathway on cancer growth and proliferation in ovarian cancer is very limited, and the effects of related molecules/pathways on tumor metastasis remain to be investigated [40]. This evidence concerns the gene FOXP3 and ovarian carcinoma.